» Authors » Mohammad Reza Rostami

Mohammad Reza Rostami

Explore the profile of Mohammad Reza Rostami including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 76
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rostami T, Rad S, Rostami M, Mirhosseini S, Alemi H, Khavandgar N, et al.
Cell Transplant . 2024 Apr; 33:9636897241246351. PMID: 38680015
While exagamglogene autotemcel (Casgevy) and lovotibeglogene autotemcel (Lyfgenia) have been approved by the US Food and Drug Administration (FDA) as the first cell-based gene therapies for the treatment of patients...
2.
Rostami T, Rostami M, Mirhosseini A, Mohammadi S, Nikbakht M, Alemi H, et al.
Stem Cell Res Ther . 2024 Apr; 15(1):111. PMID: 38644499
Background: Graft failure (GF) is a rare but serious complication after allogeneic hematopoietic stem cell transplantation (HSCT). Prevention of graft failure remains the most advisable approach as there is no...
3.
Nabizadeh F, Balabandian M, Rostami M, Owji M, Sahraian M, Bidadian M, et al.
Curr J Neurol . 2023 Nov; 21(3):144-150. PMID: 38011341
Cognitive impairments in patients with multiple sclerosis (MS) are suggested as a prognostic factor for disease development, and consequently higher disability and more deficits in daily and social activities. In...
4.
Tavakoli Shiraji S, Rostami M, Kamranzadeh Foumani H, Mousavi S, Vaezi M, Rad S, et al.
Int J Hematol Oncol Stem Cell Res . 2023 Oct; 17(3):156-166. PMID: 37817970
: Thrombotic thrombocytopenic purpura (TTP) is associated with microangiopathic hemolytic anemia, thrombocytopenia, and microvascular thrombosis. No comprehensive report exists on clinical characteristics and risk factors of relapse and mortality in...
5.
Amarasena L, Samir N, Sealy L, Hu N, Rostami M, Isaacs D, et al.
Arch Dis Child . 2022 Dec; 108(3):185-191. PMID: 36549868
Objective: To describe the health and well-being of children and young people (CYP) seeking asylum subjected to Australia's immigration policy of indefinite mandatory detention on Nauru. Design: Cross-sectional analysis of...
6.
Rostami T, Aghabeigi S, Kiumarsi A, Kasaeian A, Kardoust Parizi M, Mirhosseini A, et al.
J Pediatr Urol . 2022 Nov; 19(1):54.e1-54.e8. PMID: 36443142
Background: Hemorrhagic cystitis (HC) is an important adverse event experienced after hematopoietic stem cell transplantation (HSCT). Severe HC could lead to significant morbidity, prolonged hospitalization with increased health-care costs, and...
7.
Nabizadeh F, Kankam S, Balabandian M, Hashemi S, Sharifkazemi H, Rostami M
Exp Gerontol . 2022 Jul; 166:111890. PMID: 35843348
Objective: There is a shred of growing evidence demonstrating that diabetic patients are at higher risk of developing Alzheimer's disease compared to the general population. The previous investigation showed the...
8.
Nabizadeh F, Seyedalhosseini Z, Balabandian M, Rostami M
J Clin Neurosci . 2022 Jul; 102:101-108. PMID: 35777112
Background: There were concerns about the psychological outcomes of coronavirus disease from the beginning of the pandemic. Parkinson's disease (PD) patients seem to be more vulnerable to mental health disorders...
9.
Nabizadeh F, Balabandian M, Rostami M, Ward R, Ahmadi N, Pourhamzeh M
Aging Clin Exp Res . 2022 Jun; 34(9):2139-2147. PMID: 35648357
Alzheimer's disease (AD) is a progressive neurodegenerative disease associated with dementia and is a serious concern for the health of individuals and government health care systems worldwide. Gray matter atrophy...
10.
Nabizadeh F, Balabandian M, Sodeifian F, Rezaei N, Rostami M, Naser Moghadasi A
Mult Scler Relat Disord . 2022 Apr; 62:103795. PMID: 35472834
Introduction: There are increasing reports of COVID-19 related neurological complications which may be due to direct viral invasion, or immune mediated inflammatory diseases such as autoimmune encephalitis and ADEM (acute...